{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:46:50Z","timestamp":1648914410335},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T00:00:00Z","timestamp":1377907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00108-013-3291-y","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T09:56:27Z","timestamp":1377770187000},"page":"1197-1204","source":"Crossref","is-referenced-by-count":1,"title":["H\u00e4matoonkologische Krankheitsbilder"],"prefix":"10.1007","volume":"54","author":[{"given":"L.H.","family":"Lindner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,31]]},"reference":[{"key":"3291_CR1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","volume":"325","author":"Bell","year":"1991","unstructured":"Bell WR, Braine HG, Ness PM, Kickler TS (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325:398\u2013403","journal-title":"N Engl J Med"},{"key":"3291_CR2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.2007.13.4403","volume":"26","author":"Blanke","year":"2008","unstructured":"Blanke CD, Demetri GD, Mehren M von et al (2008) Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol 26:620\u2013625","journal-title":"J Clin Oncol"},{"key":"3291_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood-2005-01-0173","volume":"106","author":"Chadha","year":"2005","unstructured":"Chadha P, Rademaker AW, Mendiratta P et al (2005) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood 106:241\u2013246","journal-title":"Blood"},{"key":"3291_CR4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMc1202124","volume":"366","author":"Dietrich","year":"2012","unstructured":"Dietrich S, Glimm H, Andrulis M et al (2012) BRAF inhibition in refractory hairy-cell leukemia. N Engl J Med 366:2038\u20132040","journal-title":"N Engl J Med"},{"key":"3291_CR5","doi-asserted-by":"crossref","first-page":"708596","DOI":"10.4061\/2011\/708596","volume":"2011","author":"Downs-Kelly","year":"2011","unstructured":"Downs-Kelly E, Rubin BP (2011) Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies. Pathol Res Int 2011:708596","journal-title":"Pathol Res Int"},{"key":"3291_CR6","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/cncr.21447","volume":"104","author":"Else","year":"2005","unstructured":"Else M, Ruchlemer R, Osuji N et al (2005) Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer 104:2442\u20132448","journal-title":"Cancer"},{"key":"3291_CR7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2009.07668.x","volume":"145","author":"Else","year":"2009","unstructured":"Else M, Dearden CE, Matutes E et al (2009) Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 145:733\u2013740","journal-title":"Br J Haematol"},{"key":"3291_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.20390","volume":"80","author":"Franchini","year":"2005","unstructured":"Franchini M, Gandini G, Di Paolantonio T, Mariani G (2005) Acquired hemophilia A: a concise review. Am J Hematol 80:55\u201363","journal-title":"Am J Hematol"},{"key":"3291_CR9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2009.24.2099","volume":"28","author":"Gastrointestinal","year":"2010","unstructured":"Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (2010) Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol 28:1247\u20131253","journal-title":"J Clin Oncol"},{"key":"3291_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","volume":"45","author":"Green","year":"1981","unstructured":"Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost 45:200\u2013203","journal-title":"Thromb Haemost"},{"key":"3291_CR11","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/sj.leu.2403418","volume":"18","author":"Jehn","year":"2004","unstructured":"Jehn U, Bartl R, Dietzfelbinger H et al (2004) An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Leukemia 18:1476\u20131481","journal-title":"Leukemia"},{"key":"3291_CR12","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.2012.347","volume":"307","author":"Joensuu","year":"2012","unstructured":"Joensuu H, Eriksson M, Sundby Hall K et al (2012) One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA 307:1265\u20131272","journal-title":"JAMA"},{"key":"3291_CR13","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","volume":"27","author":"Kielstein","year":"2001","unstructured":"Kielstein JT, Beutel G, Fleig S et al (2001) Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 27:3807\u20133815","journal-title":"Nephrol Dial Transplant"},{"key":"3291_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM200107263450402","volume":"345","author":"Kreitman","year":"2001","unstructured":"Kreitman RJ, Wilson WH, Bergeron K et al (2001) Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med 345:241\u2013247","journal-title":"N Engl J Med"},{"key":"3291_CR15","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","volume":"345","author":"Menne","year":"2012","unstructured":"Menne J, Nitschke M, Stingele R et al (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 345:e4565","journal-title":"BMJ"},{"key":"3291_CR16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pas.0000146010.92933.de","volume":"29","author":"Miettinen","year":"2005","unstructured":"Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52\u201368","journal-title":"Am J Surg Pathol"},{"key":"3291_CR17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325:393\u2013397","journal-title":"N Engl J Med"},{"key":"3291_CR18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/1097-0142(20010315)91:6<1067::AID-CNCR1101>3.0.CO;2-4","volume":"91","author":"Sallah","year":"2001","unstructured":"Sallah S, Wan JY (2001) Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer 91:1067\u20131074","journal-title":"Cancer"},{"key":"3291_CR19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S et al (2012) Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158:323\u2013335","journal-title":"Br J Haematol"},{"key":"3291_CR20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2516.2007.01474.x","volume":"13","author":"Sumner","year":"2007","unstructured":"Sumner MJ, Geldziler BD, Pedersen M, Seremetis S (2007) Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia 13:451\u2013461","journal-title":"Haemophilia"},{"key":"3291_CR21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1471-0528.2012.03469.x","volume":"119","author":"Tengborn","year":"2012","unstructured":"Tengborn L, Baudo F, Huth-Kuhne A et al (2012) Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG 119:1529\u20131537","journal-title":"BJOG"},{"key":"3291_CR22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","volume":"364","author":"Verweij","year":"2004","unstructured":"Verweij J, Casali PG, Zalcberg J et al (2004) Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 364:1127\u20131134","journal-title":"Lancet"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-013-3291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-013-3291-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-013-3291-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T11:59:57Z","timestamp":1563796797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-013-3291-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,31]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["3291"],"URL":"https:\/\/doi.org\/10.1007\/s00108-013-3291-y","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,31]]}}}